Physician profile
Randall Anselmo
NPI 1417024936
$1,005.58
in general payments reported to CMS, 2019-2025
13 companies · $735 in 2025
The $735 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $270 · 2025: $735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,006.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,005.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $447.51 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Integra Lifesciences Corporation | $127.02 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Mayne Pharma Commercial LLC | $124.89 | 2025 | |
| Medtronic, INC. | $55.71 | 2025 | Interstim |
| Alk-Abello, INC | $46.81 | 2024-2025 | Odactra, Grastek, Ragwitek |
| Daiichi Sankyo INC. | $38.00 | 2025 | Injectafer |
| Lilly USA, LLC | $35.43 | 2025 | Mounjaro, Zepbound |
| Eisai INC. | $32.47 | 2025 | |
| Inspire Medical Systems, INC. | $25.03 | 2024 | Inspire |
| Sanofi-Aventis U.S. LLC | $24.85 | 2025 | |
| Janssen Pharmaceuticals, INC | $17.01 | 2025 | Spravato |
| Astellas Pharma US INC | $16.94 | 2024 | Veozah |
| Exact Sciences Corporation | $13.91 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Anselmo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.